ACADIA Pharmaceuticals
ACAD
#3888
Rank
A$4.91 B
Marketcap
A$28.67
Share price
0.30%
Change (1 day)
-11.40%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): A$0.17 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.13 Billion. In 2025 the company made an earning of A$0.19 Billion a decrease over its 2024 earnings that were of A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.17 B-9.98%
2025 A$0.19 B-46.18%
2024 A$0.37 B-605.67%
2023 -A$73.36 Million-76.09%
2022 -A$0.31 Billion27.41%
2021 -A$0.25 Billion-40.38%
2020 -A$0.41 Billion19.88%
2019 -A$0.34 Billion-3.92%
2018 -A$0.36 Billion-15.04%
2017 -A$0.42 Billion6.33%
2016 -A$0.39 Billion64.55%
2015 -A$0.24 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$54.55 Million81.93%
2012 -A$29.98 Million-8.73%
2011 -A$32.85 Million-251.39%
2010 A$21.69 M-133.2%
2009 -A$65.36 Million-30.82%
2008 -A$94.47 Million6.43%
2007 -A$88.77 Million25.89%
2006 -A$70.51 Million36.99%
2005 -A$51.47 Million37.22%
2004 -A$37.51 Million19.96%
2003 -A$31.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.66 B 21,493.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.92 B 5,590.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.28 B 27,580.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.11 B 9,713.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion-252.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$55.53 Million-131.83%๐Ÿ‡บ๐Ÿ‡ธ USA